KMB Accelerates Growth Through Digital & Club Channel Expansion
AI Sentiment
Positive
7/10
as of 12-05-2025 3:43pm EST
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It intends to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.
| Founded: | 1910 | Country: | United States |
| Employees: | N/A | City: | IRVING |
| Market Cap: | 35.5B | IPO Year: | N/A |
| Target Price: | $129.58 | AVG Volume (30 days): | 6.2M |
| Analyst Decision: | Hold | Number of Analysts: | 12 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.91 | EPS Growth: | -23.42 |
| 52 Week Low/High: | $99.22 - $150.45 | Next Earning Date: | 10-30-2025 |
| Revenue: | $19,724,000,000 | Revenue Growth: | 11.62% |
| Revenue Growth (this year): | -15.45% | Revenue Growth (next year): | 3.10% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
KMB Breaking Stock News: Dive into KMB Ticker-Specific Updates for Smart Investing
AI Sentiment
Positive
7/10
AI Sentiment
Positive
6/10
AI Sentiment
Positive
6/10
AI Sentiment
Positive
7/10
See how KMB stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "KMB Kimberly-Clark Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.